Home > Publications database > Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study. > print |
001 | 288993 | ||
005 | 20250514132959.0 | ||
024 | 7 | _ | |a 10.1002/cac2.12526 |2 doi |
024 | 7 | _ | |a pmid:38487965 |2 pmid |
024 | 7 | _ | |a 1000-467X |2 ISSN |
024 | 7 | _ | |a 1944-446X |2 ISSN |
024 | 7 | _ | |a 2523-3548 |2 ISSN |
024 | 7 | _ | |a altmetric:160777172 |2 altmetric |
037 | _ | _ | |a DKFZ-2024-00540 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Jansana, Anna |0 0000-0001-8504-1618 |b 0 |
245 | _ | _ | |a Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study. |
260 | _ | _ | |a Hoboken, NJ |c 2024 |b Wiley |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1716466452_27470 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2024 May;44(5):593-597 |
536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Auguste, Aviane |b 1 |
700 | 1 | _ | |a Kvaskoff, Marina |b 2 |
700 | 1 | _ | |a Fournier, Agnès |b 3 |
700 | 1 | _ | |a Fontvieille, Emma |b 4 |
700 | 1 | _ | |a Peruchet-Noray, Laia |b 5 |
700 | 1 | _ | |a Biessy, Carine |b 6 |
700 | 1 | _ | |a Cordova, Reynalda |b 7 |
700 | 1 | _ | |a Nielsen Petersen, Kristina Elin |b 8 |
700 | 1 | _ | |a Tjønneland, Anne |b 9 |
700 | 1 | _ | |a Katzke, Verena |0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |b 10 |u dkfz |
700 | 1 | _ | |a Kaaks, Rudolf |0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |b 11 |u dkfz |
700 | 1 | _ | |a Ricceri, Fulvio |b 12 |
700 | 1 | _ | |a Panico, Salvatore |b 13 |
700 | 1 | _ | |a Contiero, Paolo |b 14 |
700 | 1 | _ | |a Sánchez, Maria-Jose |b 15 |
700 | 1 | _ | |a Castilla, Jesus |b 16 |
700 | 1 | _ | |a Crous-Bou, Marta |b 17 |
700 | 1 | _ | |a Heath, Alicia |b 18 |
700 | 1 | _ | |a Aglago, Elom Kouassivi |b 19 |
700 | 1 | _ | |a Weiderpass, Elisabete |b 20 |
700 | 1 | _ | |a Gunter, Marc James |b 21 |
700 | 1 | _ | |a Ferrari, Pietro |b 22 |
700 | 1 | _ | |a Riboli, Elio |b 23 |
700 | 1 | _ | |a Viallon, Vivian |b 24 |
700 | 1 | _ | |a Freisling, Heinz |b 25 |
773 | _ | _ | |a 10.1002/cac2.12526 |g p. cac2.12526 |0 PERI:(DE-600)2922913-3 |n 5 |p 593-597 |t Cancer communications |v 44 |y 2024 |x 1000-467X |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/288993/files/Cancer%20Communications%20-%202024%20-%20Jansana%20-%20Impact%20of%20pre%E2%80%90existing%20cardiometabolic%20diseases%20on%20metastatic%20cancer%20stage%20at.pdf |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/288993/files/Cancer%20Communications%20-%202024%20-%20Jansana%20-%20Impact%20of%20pre%E2%80%90existing%20cardiometabolic%20diseases%20on%20metastatic%20cancer%20stage%20at.pdf?subformat=pdfa |x pdfa |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:288993 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-02T09:05:11Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-02T09:05:11Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-05-02T09:05:11Z |
915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2023-05-02T09:05:11Z |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CANCER COMMUN : 2022 |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-27 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-27 |
915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b CANCER COMMUN : 2022 |d 2023-10-27 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-10-27 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-10-27 |
920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C020-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|